UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 248

Sortiert nach

Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection

Revista Española de Sanidad Penitenciaria, 2017-12, Vol.19 (3), p.87-97

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation

American journal of transplantation, 2009-07, Vol.9 (7), p.1591-1601

2009

Link zum Volltext

Verfügbarkeit prüfen

186 AN INCREASED LIVER STIFFNESS MEASUREMENT ONE YEAR AFTER TRANSPLANTATION IS VERY ACCURATE AT PREDICTING CLINICAL OUTCOMES IN HEPATITIS C RECURRENCE

Journal of hepatology, 2012-04, Vol.56, p.S80-S80

2012

Link zum Volltext

Verfügbarkeit prüfen

207 PERIPORTAL SINUSOIDAL FIBROSIS IS AN EARLY MARKER OF PORTAL HYPERTENSION AND SIGNIFICANT FIBROSIS IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2012-04, Vol.56, p.S88-S88

2012

Link zum Volltext

Verfügbarkeit prüfen

187 ANTIVIRAL THERAPY IN RECURRENT HEPATITIS C: ADVANCED DONOR AGE AND FEMALE RECIPIENT GENDER IDENTIFY NON RESPONDERS AT HIGHER RISK OF GRAFT LOSS

Journal of hepatology, 2012-04, Vol.56, p.S80-S81

2012

Link zum Volltext

Verfügbarkeit prüfen

108 EARLY ASSESSMENT OF LIVER STIFFNESS IDENTIFIES TWO DIFFERENT PATTERNS OF LIVER FIBROSIS PROGRESSION IN PATIENTS WITH HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION

Journal of hepatology, 2008, Vol.48, p.S48-S48

2008

Link zum Volltext

Verfügbarkeit prüfen

Donor and Recipient IL28B Polymorphisms in HCV‐Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation

American journal of transplantation, 2011-05, Vol.11 (5), p.1051-1057

2011

Link zum Volltext

Verfügbarkeit prüfen

14 EFFICAY AND SAFETY OF PEGYLATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS AWAITING LIVER TRANSPLANTATION: A CASE-CONTROL STUDY

Journal of hepatology, 2008, Vol.48, p.S8-S8

2008

Link zum Volltext

Verfügbarkeit prüfen

[87] EFFICACY OF ANTIVIRAL THERAPY ON DISEASE PROGRESSION IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A RANDOMIZED CONTROLLED STUDY

Journal of hepatology, 2007, Vol.46, p.S39-S40

2007

Link zum Volltext

Verfügbarkeit prüfen

Survival analysis and response to ursodeoxycholic acid in patients with primary biliary cholangitis

Journal of hepatology, 2017, Vol.66 (1), p.S352-S352

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival in patients with chronic hepatitis C and mild-moderate fibrosis according to antiviral treatment response

Journal of hepatology, 2017, Vol.66 (1), p.S494-S494

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

Journal of hepatology, 2017, Vol.66 (1), p.S717-S717

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantification of HBsAg (HBsAg-Q) in HBeAg-Negative Patients Receiving Nucleos(T)ide Analogues to Predict the Loss of HBsAg

Journal of hepatology, 2016, Vol.64 (2), p.S379-S379

2016

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Liver Fibrosis (ELF) Test Quantification in HBeAg-Negative Patients with Nucleos(T)Ide Analogues 1, 3, 5 and 8 Years after Liver Biopsy

Journal of hepatology, 2016, Vol.64 (2), p.S730-S730

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and Management of Drug-Drug Interactions (DDIs) with Ombitasvir (OBV), Paritaprevir/R (PRV/r) ± Dasabuvir (DBV) ± Ribavirin (RBV) in Pacients with Chronic Hepatitis C in Real-Life Clinical Practice

Journal of hepatology, 2016, Vol.64 (2), p.S761-S761

2016

Link zum Volltext

Verfügbarkeit prüfen

Non-Invasive Assessment of Steatosis and Liver Fibrosis in Overweight and Obese Patients

Journal of hepatology, 2016, Vol.64 (2), p.S500-S500

2016

Link zum Volltext

Verfügbarkeit prüfen

Non-Invasive Evaluation of Chronic Hepatitis C Patients with Moderate Fibrosis (F2) Long-Term Impact of Antiviral Treatment

Journal of hepatology, 2016, Vol.64 (2), p.S726-S726

2016

Link zum Volltext

Verfügbarkeit prüfen

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

Journal of hepatology, 2016, Vol.64 (2), p.S273-S273

2016

Link zum Volltext

Verfügbarkeit prüfen

High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry

Journal of hepatology, 2017, Vol.66 (1), p.S311-S311

2017

Link zum Volltext

Verfügbarkeit prüfen

P0190 : Predictive model of mortality in cirrhotic patients with high risk spontaneous bacterial peritonitis

Journal of hepatology, 2015-04, Vol.62, p.S375-S375

2015

Link zum Volltext

Verfügbarkeit prüfen

P0515 : Biological stability and diagnostic accuracy of ELF® (enhanced liver fibrosis test) to identify liver fibrosis in patients with chronic hepatitis C using cryopreserved serum samples during 25 years

Journal of hepatology, 2015-04, Vol.62, p.S508-S508

2015

Link zum Volltext

Verfügbarkeit prüfen

P0846 : Evaluation of adherence to telaprevir (TVR) and boceprevir (BOC) using different thresholds

Journal of hepatology, 2015-04, Vol.62, p.S656-S656

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of Hepatitis C virus resistance-associated substitutions after interferon-free treatment failure by massive parallel sequencing

Journal of hepatology, 2017, Vol.66 (1), p.S731-S731

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(241)

Publikationsform

Artikel
(243)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Gastroenterology And Hepatology
(36)
Life Sciences & Biomedicine
(26)
Technology
(26)
Urology
(22)
Humans
(18)
Male
(16)
Female
(15)
Instruments & Instrumentation
(15)
Aged
(14)
Middle Aged
(14)
Physical Sciences
(14)
Adult
(12)
Instrumentation Related To Nuclear Science And Technology
(11)
Physics
(11)
Xenon
(10)
Biological And Medical Sciences
(8)
Beta Decay
(7)
Electroluminescence
(7)
Surgery
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection

Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation

Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort

186 AN INCREASED LIVER STIFFNESS MEASUREMENT ONE YEAR AFTER TRANSPLANTATION IS VERY ACCURATE AT PREDICTING CLINICAL OUTCOMES IN HEPATITIS C RECURRENCE

Effectiveness and Safety of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir Patients with Genotype 1 Chronic Hepatitis C Virus Infection: Results from the Spanish Real World Cohort

207 PERIPORTAL SINUSOIDAL FIBROSIS IS AN EARLY MARKER OF PORTAL HYPERTENSION AND SIGNIFICANT FIBROSIS IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION

187 ANTIVIRAL THERAPY IN RECURRENT HEPATITIS C: ADVANCED DONOR AGE AND FEMALE RECIPIENT GENDER IDENTIFY NON RESPONDERS AT HIGHER RISK OF GRAFT LOSS

108 EARLY ASSESSMENT OF LIVER STIFFNESS IDENTIFIES TWO DIFFERENT PATTERNS OF LIVER FIBROSIS PROGRESSION IN PATIENTS WITH HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION

Donor and Recipient IL28B Polymorphisms in HCV‐Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation

14 EFFICAY AND SAFETY OF PEGYLATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS AWAITING LIVER TRANSPLANTATION: A CASE-CONTROL STUDY

[87] EFFICACY OF ANTIVIRAL THERAPY ON DISEASE PROGRESSION IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A RANDOMIZED CONTROLLED STUDY

Survival analysis and response to ursodeoxycholic acid in patients with primary biliary cholangitis

Survival in patients with chronic hepatitis C and mild-moderate fibrosis according to antiviral treatment response

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

Quantification of HBsAg (HBsAg-Q) in HBeAg-Negative Patients Receiving Nucleos(T)ide Analogues to Predict the Loss of HBsAg

Enhanced Liver Fibrosis (ELF) Test Quantification in HBeAg-Negative Patients with Nucleos(T)Ide Analogues 1, 3, 5 and 8 Years after Liver Biopsy

Prevalence and Management of Drug-Drug Interactions (DDIs) with Ombitasvir (OBV), Paritaprevir/R (PRV/r) ± Dasabuvir (DBV) ± Ribavirin (RBV) in Pacients with Chronic Hepatitis C in Real-Life Clinical Practice

Non-Invasive Assessment of Steatosis and Liver Fibrosis in Overweight and Obese Patients

Non-Invasive Evaluation of Chronic Hepatitis C Patients with Moderate Fibrosis (F2) Long-Term Impact of Antiviral Treatment

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry

P0190 : Predictive model of mortality in cirrhotic patients with high risk spontaneous bacterial peritonitis

P0515 : Biological stability and diagnostic accuracy of ELF® (enhanced liver fibrosis test) to identify liver fibrosis in patients with chronic hepatitis C using cryopreserved serum samples during 25 years

P0846 : Evaluation of adherence to telaprevir (TVR) and boceprevir (BOC) using different thresholds

Molecular characterization of Hepatitis C virus resistance-associated substitutions after interferon-free treatment failure by massive parallel sequencing

Suchergebnisse filtern